The content on this site is intended for healthcare professionals only
Professor Gerard discusses recent clinical trials including the TME and CRO7 trials that have shown the importance of preoperative radiotherapy in reducing relapse rate and the STAR trial that has shown the benefits of combining of chemotherapy and radiotherapy, escalating the radiotherapy dose to 50 Gy and that capecitabine should be used without oxaliplatin when treating T3 and T4 tumours.
Ethics-Guided Radiation Therapy (EGRT): A proposal to refine the practice
Multiple Myeloma: evolving paradigm - Panel Discussion
TARGIT trial in intraoperative radiotherapy
Choosing Wisely for young women with breast cancer: Radiotherapy
Choosing Wisely in endometrial & cervix cancers: Medical therapy
Intraoperative radiotherapy at Fortis Healthcare Hospital
Intraoperative radiotherapy: Techniques, applications, and evidence
The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant therapy for locally advanced RC
Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma
